Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: H01CC01

Ganirelix Gedeon Richter(ganirelix acetate)

Reproductive Techniques, Assisted;Ovulation Induction;Infertility, Female

Marketing Authorisation Holder: Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)

EMA Authorisation: 15/07/2022

INN: ganirelix

Indication

Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ganirelix Gedeon Richter — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.